Publication | Closed Access

High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay

Hematological MalignancyBreast OncologyDna DamageMedicineHematologyImmunologyPathologyBreast CancerCancer TreatmentOncologyCancer ResearchHigh-dose Combination